Emmes

Join Emmes at the Alzheimer's Association International Conference (AAIC) 2024 Conference at Booth #940 July 28- August 1. Our team of experts will be there to discuss how our innovative AI solutions tailored for complex neurodegenerative trials and Ai enabled excellence in CNS research and precision data collection can help support your trial. With over 180 CNS trials completed, we offer a combination of clinical expertise and innovative support for neurodegenerative trials to drive precision data collection, management and integrity with real-time insights for maximum results. Learn more at https://hubs.la/Q02G_3Fd0 Steffanie Wilson, PhD, Courtney Nelson-Douthit, Julia Hamilos, Victoria Coleman-Cowger, Stephanie H. Bagully, PhD, Matthew Donnelly, Alzheimer's Association® #AAIC2024 #AlzheimersResearch #CNSResearch #Emmes #CRO

We are excited to announce that outcomes from the NCI-AMC ANCHOR study, where Emmes served as the Data Management Center, has resulted in a revision of the Centers for Disease Control's guidelines for anal cancer screening & prevention. Click the link below to find out more. https://hubs.la/Q02GrK920

Join Emmes at the Military Health System Research Symposium (MHSRS) 2024 to meet our team of experts including Amberlie Ann Clutterbuck, PhD, Jessie K Kennedy, MPH, Natalia de Val, Jeanine May, Angela Terhune Hargrove, and Victoria Coleman-Cowger. We'll be discussing our collaboration opportunities and our experience critical care. Emmes offers clinical expertise and differentiated capabilities including advanced data management, regulatory affairs, and biostatistical analysis to support military health research through innovative solutions. Schedule a Meeting at MHSRS here: https://hubs.la/Q02G53Zp0

Download VaxTRIALS, part of Emmes Group, our sister company's eBook: https://hubs.la/Q02FfYcR0 for expert tips on navigating the complexities of regulatory and ethical approvals in vaccine trials. Leveraging their global footprint, local knowledge, and decades of clinical excellence, the eBook provides valuable strategies on expediting approvals, streamlining processes and more to help drive rapid and efficient trials. #VaccineTrials #ClinicalResearch #RegulatoryApprovals #CROpartner #ClinicalTrials

Engaging key study personnel early is crucial for aligning on study goals and ensuring efficient communication. Our sister company, VaxTRIALS, part of Emmes Group's proactive approach to feasibility exercises coupled with our tech-enabled solutions allows for rapid enrollment and seamless coordination, ensuring trials are quicker, flexible, and more cost-effective. Discover more strategies for streamlining your vaccine trials in our latest eBook: https://hubs.la/Q02DqqjL0 #VaccineTrials #ClinicalTrials #TrialEnrollement #StudyStartUp #CROpartner #ClinicalResearch

We are thrilled to announce that Amber Sapp, PT, DPT has been nominated for the RARE Champion in Research Award by Global Genes! At Emmes, we’re incredibly proud to see Amber’s dedication and passion for advancing rare disease research recognized with this prestigious nomination. Congratulations, Amber! "I am deeply honored and grateful to be nominated for the RARE Champion in Research Award by Global Genes. As someone passionate and dedicated to advancing research for rare diseases, this recognition is truly humbling and inspires me to continue this important work,” says Amber. Winners will be announced later this month. Stay tuned! #RAREChampion #GlobalGenes #RareDiseaseResearch #Emmes #CRO

Emmes' Kriszha S. shared her gratitude after speaking at #ASCEND2024: "I'm incredibly thankful for the opportunity to present a poster and presentation about the Angelman Syndrome Video Assessment (ASVA) and how the video assessment methodology can be adapted for Rett Syndrome. I'd like to thank the International Rett Syndrome Foundation for accepting my abstract and hosting such a wonderful event. I always enjoy the thoughtful discussion with families and showcasing the innovative work done by Emmes." Visit https://hubs.la/Q02Dhy4v0 to learn more. #EmmesEndpointSolutions #Emmes #CRO #ClinicalTrials #RareDisease

Read ET Pharma’s interview with Archana Sarda, Managing Director of Emmes India, where she discusses how AI is revolutionizing clinical trials, making them faster and smarter than ever before. Sarda discusses how, with the power of AI, we can enhance trial efficiency, improve data accuracy, and accelerate the development of new treatments. Additionally, she provides her thoughts on how by integrating AI-driven insights we can optimize trial designs and decision-making processes, ultimately bringing life-saving therapies to patients more swiftly. Click here to read her full interview: https://hubs.la/Q02D2Sc40 #ClinicalTrials #AI #HealthcareInnovation #Emmes #EmmesIndia

Along with our presence at #ASCEND2024 this week, Emmes aims to drive clinical trial success across the Rare Disease landscape through a combination of cutting-edge technology and clinical expertise. Our dedicated team is committed to advancing research and delivering impactful solutions for patients worldwide. Watch the video below or visit https://hubs.la/Q02CCmX40 to learn more. #CRO #rarediseases #clinicaltrials #EmmesEndpointSolutions

We're excited to share Kriszha S. will be presenting a poster titled "Quantified Assessment of Function in Rett Syndrome with Home Video" at the ASCEND 2024 Rett Syndrome National Summit, on June 19th at 3:10PM. Kriszha will share her innovative research on using home video to assess function in Rett Syndrome, a groundbreaking approach that promises to enhance our understanding and treatment of this condition. We look forward to seeing the impact of her work and are proud to support her as she contributes to this important field. For more information on the event, visit: https://hubs.la/Q02C1h040 #EmmesEndpointSolutions #ASCEND2024 #RettSyndrome #ClinicalResearch #Emmes